Literature DB >> 2451481

Expression of the protooncogenes in psoriatic lesions.

V N Mordovtsev1, I V Starkov, E R Zabarovsky, L L Kisselev.   

Abstract

The expression of cellular protooncogenes in psoriatic lesions was studied. RNA isolated from involved skin of psoriatic patients was subjected to dot-blot hybridization with cloned viral Ki-ras, myc, abl, fos, src, erbB, mos, sis, fes, and yes oncogenes. RNA isolated from the aortal epithelium, peripheral blood lymphocytes, and skin of the nonpsoriatic patients was used as control. The results indicate that the expression of Ki-ras, myc, fos, and abl genes is elevated in psoriatic lesions. The data of this work suggest that the activity of cellular oncogenes may play an important role in the development of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451481     DOI: 10.1007/bf00412681

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  21 in total

1.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

2.  Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells.

Authors:  B Vennström; C Moscovici; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

3.  Calmodulin levels are grossly elevated in the psoriatic lesion.

Authors:  P C van de Kerkhof; P E van Erp
Journal:  Br J Dermatol       Date:  1983-02       Impact factor: 9.302

4.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.

Authors:  T Curran; G Peters; C Van Beveren; N M Teich; I M Verma
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

6.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.

Authors:  S P Goff; E Gilboa; O N Witte; D Baltimore
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

7.  Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells.

Authors:  B Vennström; L Fanshier; C Moscovici; J M Bishop
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

8.  Human nucleotide sequences related to the transforming gene of a murine sarcoma virus: studies with cloned viral and cellular DNAs.

Authors:  I M Chumakov; E R Zabarovsky; V S Prassolov; V L Mett; L L Kisselev
Journal:  Gene       Date:  1982-01       Impact factor: 3.688

9.  Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus.

Authors:  N Kitamura; A Kitamura; K Toyoshima; Y Hirayama; M Yoshida
Journal:  Nature       Date:  1982-05-20       Impact factor: 49.962

Review 10.  Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology.

Authors:  H Mayer; W Bollag; R Hänni; R Rüegg
Journal:  Experientia       Date:  1978-09-15
View more
  3 in total

1.  No evidence for the mutation of ras gene in psoriatic epidermis.

Authors:  H Takahashi; H Iizuka; M Katagiri
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Regulation of fos-lacZ fusion gene expression in primary mouse epidermal keratinocytes isolated from transgenic mice.

Authors:  W B Bollag; Y Xiong; J Ducote; C S Harmon
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

3.  Vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients.

Authors:  M Casado; M Martin; A Muñoz; J Bernal
Journal:  J Endocrinol Invest       Date:  1998-09       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.